Foxe D, Hu A, Cheung S C, Ahmed R M, Cordato N J, Devenney E, Hwang Y T, Halliday G M, Mueller N, Leyton C E, Hodges J R, Burrell J R, Irish M, Piguet O
School of Psychology, The University of Sydney, 94 Mallett St, Sydney, NSW 2006, Australia.
Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia.
Brain Commun. 2022 Jul 7;4(4):fcac161. doi: 10.1093/braincomms/fcac161. eCollection 2022.
The Addenbrooke's Cognitive Examination III is a brief cognitive screening tool that is widely used for the detection and monitoring of dementia. Recent findings suggest that the three variants of primary progressive aphasia can be distinguished based on their distinct profiles on the five subdomain scores of this test. Here, we investigated the utility of the Addenbrooke's Cognitive Examination III to differentiate the primary progressive aphasia variants based on their item-by-item performance profiles on this test. From these results, we created an interactive primary progressive aphasia Addenbrooke's Cognitive Examination III calculator which predicts the variant based on a patient's unique item-by-item profile. Twenty-eight logopenic variant, 25 non-fluent variant and 37 semantic variant primary progressive aphasia patients and 104 healthy controls completed the Addenbrooke's Cognitive Examination III at first clinical presentation. Multinomial regression analyses were conducted to establish performance profiles among groups, and R Shiny from RStudio was used to create the interactive Addenbrooke's Cognitive Examination III diagnostic calculator. To verify its accuracy, probability values of the regression model were derived based on a 5-fold cross-validation of cases. The calculator's accuracy was then verified in an independent sample of 17 logopenic, 19 non-fluent and 13 semantic variant primary progressive aphasia patients and 68 Alzheimer's disease patients who had completed the Addenbrooke's Cognitive Examination III (or an older version of this test: Revised) and had amyloid-PET imaging and/or brain autopsy pathological confirmation. Cross-validation of cases in the calculator model revealed different rates of sensitivity in classifying variants: semantic = 100%, non-fluent = 80.6% and logopenic = 79.9%; healthy controls were distinguished from primary progressive aphasia patients with 100% sensitivity. Verification of amyloid and/or autopsy-confirmed patients showed that the calculator correctly classified 10/13 (77%) semantic variant, 3/19 (16%) non-fluent variant and 4/17 (24%) logopenic variant patients. Importantly, for patients who were not classified, diagnostic probability values mostly pointed toward the correct clinical diagnosis. Furthermore, misclassified diagnoses of the primary progressive aphasia cohort were rare (1/49; 2%). Although 22 of the 68 Alzheimer's disease patients (32%) were misclassified with primary progressive aphasia, 19/22 were misclassified with the logopenic variant (i.e. falling within the same neuropathological entity). The Addenbrooke's Cognitive Examination III primary progressive aphasia diagnostic calculator demonstrates sound accuracy in differentiating the variants based on an item-by-item Addenbrooke's Cognitive Examination III profile. This calculator represents a new frontier in using data-driven approaches to differentiate the primary progressive aphasia variants.
剑桥认知功能测试第三版(Addenbrooke's Cognitive Examination III,ACE-III)是一种简短的认知筛查工具,广泛用于痴呆症的检测和监测。最近的研究结果表明,原发性进行性失语的三种变体可以根据该测试五个子领域得分的不同特征加以区分。在此,我们研究了ACE-III根据原发性进行性失语变体在该测试中的逐题表现特征来进行区分的效用。基于这些结果,我们创建了一个交互式原发性进行性失语ACE-III计算器,它可以根据患者独特的逐题表现特征预测变体类型。28例音韵性变异型、25例非流利型变异型和37例语义性变异型原发性进行性失语患者以及104名健康对照者在首次临床表现时完成了ACE-III测试。进行多项回归分析以确定各组之间的表现特征,并使用RStudio中的R Shiny创建交互式ACE-III诊断计算器。为验证其准确性,基于病例的五折交叉验证得出回归模型的概率值。然后在17例音韵性变异型、19例非流利型变异型和13例语义性变异型原发性进行性失语患者以及68例已完成ACE-III测试(或该测试的旧版本:修订版)且有淀粉样蛋白PET成像和/或脑尸检病理证实的阿尔茨海默病患者的独立样本中验证该计算器的准确性。计算器模型中病例的交叉验证显示,在区分变体类型时敏感性率不同:语义性变异型为100%,非流利型变异型为80.6%,音韵性变异型为79.9%;健康对照者与原发性进行性失语患者的区分敏感性为100%。对淀粉样蛋白和/或尸检证实的患者进行验证表明,该计算器正确分类了10/13(77%)的语义性变异型患者、3/19(16%)的非流利型变异型患者和4/17(24%)的音韵性变异型患者。重要的是,对于未被分类的患者,诊断概率值大多指向正确的临床诊断。此外,原发性进行性失语队列的误诊很少(1/49;2%)。虽然68例阿尔茨海默病患者中有22例(32%)被误诊为原发性进行性失语,但其中19/22被误诊为音韵性变异型(即属于同一神经病理实体)。ACE-III原发性进行性失语诊断计算器在根据ACE-III逐题表现特征区分变体类型方面显示出良好的准确性。该计算器代表了使用数据驱动方法区分原发性进行性失语变体的一个新前沿。